These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 15310989

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 3. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S.
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [Abstract] [Full Text] [Related]

  • 4. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG.
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H, Karakiewicz PI, Shariat SF, Capitanio U, Palapattu GS, Sagalowsky AI, Lotan Y, Schoenberg MP, Amiel GE, Lerner SP, Sonpavde G.
    J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [Abstract] [Full Text] [Related]

  • 10. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 11. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS, Seo JW, Park SJ, Lee YH, Choi YD, Cho NH, Yang SC, Hong SJ.
    Urol Int; 2009 Dec; 82(3):306-11. PubMed ID: 19440019
    [Abstract] [Full Text] [Related]

  • 12. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy.
    Dutta SC, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS.
    J Urol; 2001 Aug; 166(2):490-3. PubMed ID: 11458053
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
    Nielsen ME, Bastian PJ, Palapattu GS, Trock BJ, Schoenberg MP, Chan T, Rogers CG.
    Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
    [Abstract] [Full Text] [Related]

  • 15. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP.
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [Abstract] [Full Text] [Related]

  • 16. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M, Nitzke T, Helke C, Vogler H, Hoschke B.
    Scand J Urol Nephrol; 2004 Jun; 38(3):231-5. PubMed ID: 15204377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
    Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Lotan Y, Vazina A, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Bladder Cancer Research Consortium.
    J Urol; 2006 May; 175(5):1645-9; discussion 1649. PubMed ID: 16600721
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.